Skip to content

Apple Watch blood oxygen feature could return in America following Masimo CEO resignation

2024 September 30
by RSS Feed

Due to the patent dispute between Apple and Masimo, Apple Watches sold in the U.S. cannot offer the blood oxygen measurement feature available elsewhere around the world, but now that Masimo’s CEO has resigned, there could be a potential way to resolve the matter.

Ben Lovejoy for 9to5Mac:

Back in 2013, Apple reportedly contacted Masimo to discuss a potential collaboration between the two companies. Instead, claims Masimo, Apple used the meetings to identify staff it wanted to poach. Masimo later called the meetings a “targeted effort to obtain information and expertise.”

Apple did indeed hire a number of Masimo staff, including the company’s chief medical officer, ahead of the launch of the Apple Watch.

Masimo CEO Joe Kiano later expressed concern that Apple may have been trying to steal the company’s blood oxygen sensor technology…

However, Kiana has now resigned from the company, and been replaced by Michelle Brennan.

While neither Masimo nor Brennan have revealed the reason for this, it doesn’t seem impossible that it’s related to Kiani’s handling of the dispute. A new leader creates an opportunity for a new attitude to the matter.


Apple Watch’s Blood Oxygen app is a nice-to-have, not make-or-break, feature for all but a tiny subset of potential Apple Watch customers.


We are currently about 1/5th of the way to being sustainable with Substack subscriptions.

Not a bad start!

Please tell your Apple-loving friends about MacDailyNews on Substack and, if you’re currently a free subscriber, please consider $5/mo. or $50/year to keep MacDailyNews going. Just hit the subscribe button. Thank you!

Read on Substack

.

Source link: https://macdailynews.com/2024/09/30/apple-watch-blood-oxygen-feature-could-return-in-america-following-masimo-ceo-resignation/

Leave a Reply

Note: You may use basic HTML in your comments. Your email address will not be published.

Subscribe to this comment feed via RSS